高级搜索

颅内肿瘤患者血清LSA含量及其意义

Serum LSA quantification and clinical values in endocranial tumor patients

  • 摘要: 用血清LSA快速测定法检测经颅脑CT诊断为颅内肿瘤的患者,结果表明:颅内恶性肿瘤和转移性肿瘤组血清LSA(143±42mg/L,n=59)显着高于良性肿瘤(97±30mg/L,n=33)、非肿瘤占位(93±16mg/L,n=6)及对照组(94±18mg/L,n=80)(P>0.001);恶性肿瘤和转移肿瘤组LSA阳性率(76.3%)亦显着高于另三组(分别为9.1%、0及10%).从47例颅内恶性肿瘤分析,血清LSA含量及阳性率与肿瘤恶性程度及肿瘤包膜残缺程度呈正相关,而与肿瘤大小无明显相关性。测定血清LSA含量对颅内恶性肿瘤诊断、良恶性鉴别、恶性肿瘤手术预后分析及复发监测等,具有显着意义。

     

    Abstract: Using a fast method to measure serum lipid-bond sialic acid (LSA) of the patiengs with en-docranial tumors diagnosed by computed Tomography,the results showed that the serum LSA quan-tity of malignant or metastatic tumor group (143士42mg/L, n=59) was significantly increased than those of benign tumor (97士30mg/L,n=33),non-tumor lumps (93士16mg/L, n=6) and control (94士18mg/L, n=80);the LSA positive rate of the first group (76. 3 0 0 ) was higher than other groups (9.1%,0, 10. 0%)(P<0. 001)" It was demonstrated in 47 cases of malignant tumors that the quantities and positive rate of serum LSA was positively related to the malignant degree of the tumors and incomplete degree of their wraping membrane,but not to the sizes of the tumors. It is suggested that measuring serum LSA is valuable in diagnosis,differential diagnosis and predictive analysis before operation of endocranial malignant tumors.

     

/

返回文章
返回